HomeLVTX • NASDAQ
LAVA Therapeutics NV
add
$1.09
0.93%
After Hours:(1.83%)-0.020
$1.07
Closed: Apr 11, 6:51:17 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 4.99M | 1,313.60% |
Operating expense | -16.36M | 38.89% |
Net income | -3.97M | 37.92% |
Net profit margin | -79.56 | 95.61% |
Earnings per share | -0.13 | 41.31% |
EBITDA | -3.11M | 42.47% |
Effective tax rate | -10.58% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.58M | -19.88% |
Total assets | 80.83M | -20.50% |
Total liabilities | 53.09M | 5.52% |
Total equity | 27.75M | — |
Shares outstanding | 26.31M | — |
Price to book | 1.03 | — |
Return on assets | -9.73% | — |
Return on capital | -22.10% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.97M | 37.92% |
Cash from operations | -1.41M | 88.07% |
Cash from investing | 10.97M | 226.28% |
Cash from financing | -206.00K | -127.99% |
Net change in cash | 8.05M | 143.68% |
Free cash flow | 1.71M | 118.55% |
Previous close
$1.08
Day range
$1.08 - $1.11
Year range
$0.85 - $3.39
Market cap
28.67M USD
Avg Volume
73.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2016
Website
Employees
34
